Robert J. Moraca, MD, Marc R. Moon, MD, Jennifer S

Slides:

Advertisements

Similar presentations

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Advertisements

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

Benny Weksler, MD, Jennifer L. Sullivan, MD

Neonatal Flail Tricuspid Valve: Diagnosis and Management

Adam N. Protos, MD, Jaimin R. Trivedi, MD, MPH, William M

Unusual Gastrointestinal Bleeding After Sutureless Aortic Valve Replacement: A Word of Caution Jules Iquille, MD, Joseph Nader, MD, Eric Colpart, MD,

Jason O. Robertson, MD, Phillip S. Cuculich, MD, Lindsey L

Outcomes of Reintervention on the Autograft After Ross Procedure

Clinical Outcomes of the David V Valve-Sparing Root Replacement Compared With Bioprosthetic Valve-Conduits for Aortic Root Aneurysms Jiro Esaki, MD,

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Risk Factors Associated With Reoperation and Mortality in 252 Patients After Aortic Valve Replacement for Congenitally Bicuspid Aortic Valve Disease

Andreas Zierer, MD, Spencer J. Melby, MD, Rochus K

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan.

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J

Jonathan W. Cramer, MD, Salil Ginde, MD, Garick D. Hill, MD, Scott B

Aortic Valve Replacement Improves Survival in Severe Aortic Stenosis Associated With Severe Pulmonary Hypertension Ramdas G. Pai, MD, Padmini Varadarajan,

Outcomes of Early Mitral Valve Reoperation in the Medicare Population

Matthew L. Williams, MD, Joseph E. Bavaria, MD, Michael A

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,

Gender Differences in Long-Term Survival of Medicare Beneficiaries Undergoing Mitral Valve Operations Christina M. Vassileva, MD, Christian McNeely,

Tetralogy of Fallot: Results of a Pulmonary Valve-Sparing Strategy

Jennifer S. Lawton, MD, Nader Moazami, MD, Michael K

Radial Artery Grafts in Women: Utilization and Results

The David V Valve-Sparing Root Replacement Provides Improved Survival Compared With Mechanical Valve-conduits in the Treatment of Young Patients With.

Origins of the Cardiothoracic Surgery Network (CTSNet)

Who Do You Say You Are? The Annals of Thoracic Surgery

Andreas Zierer, MD, Rochus K. Voeller, MD, Karen E

Use of Amiodarone After Major Lung Resection

Minimally Invasive Fibrillating Heart Surgery: A Safe and Effective Approach for Mitral Valve and Surgical Ablation for Atrial Fibrillation Paul S. Massimiano,

Zain Khalpey, MD, PhD, Wernard Borstlap, Patrick O. Myers, MD, Jan D

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

The effect of ablation technology on surgical outcomes after the Cox-maze procedure: A propensity analysis Shelly C. Lall, MD, Spencer J. Melby, MD,

Prosthesis-Patient Mismatch After Aortic Valve Replacement: Impact of Age and Body Size on Late Survival Marc R. Moon, MD, Michael K. Pasque, MD, Nabil.

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Robert W. Emery, MD, Christopher C. Krogh, Kit V. Arom, MD, PhD, Ann M

Andreas Zierer, MD, Marc R. Moon, MD, Spencer J

Editorial Board, January 2010

Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit George M. Alfieris, MD, Michael F. Swartz, PhD,

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Roni M. Jacobsen, MD, Michael G. Earing, MD, Garick D

Scott P. Kaiser, BS, Spencer J

Ralph W. White, FRCS (CTh), Jeremy Rushbrook, MRCS, Mohan U

Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD

Minimally Invasive Surgical Aortic Valve Replacement Through a Right Anterior Thoracotomy: How I Teach It Mahesh K. Ramchandani, MD, Moritz C. Wyler.

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Cost-Effectiveness of Mitral Valve Repair Versus Replacement by Biologic or Mechanical Prosthesis Ariel Beresniak, MD, PhD, Brigitte Sabatier, PharmD,

Twenty-Five Year Outcomes of Tricuspid Valve Replacement Comparing Mechanical and Biologic Prostheses Andrea Garatti, MD, Giovanni Nano, MD, Giuseppe.

Tricuspid Valve Repair of Idiopathic Papillary Muscle Rupture

“Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

The Risk and Outcomes of Reoperative Tricuspid Valve Surgery

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

Early and Midterm Outcomes for Tricuspid Valve Surgery After Left-Sided Valve Surgery Choung Kyu Park, MD, Pyo Won Park, MD, Kiick Sung, MD, Young Tak.

Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis Timothy S. Lancaster,

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Aortic Valve Replacement Surgery: Comparison of Outcomes in Matched Sternotomy and PORT ACCESS Groups William T. Brinkman, MD, William Hoffman, MD, Todd.

The Impact of New Technology on Cardiothoracic Surgical Practice

Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Heinrich Koertke, MD,

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Kalpaj Parekh, MD, Bryan F. Meyers, MD, G

Umar S. Boston, MD, Joseph A. Dearani, MD, Patrick W

Michael J. Weyant, MD, Manjit S

Early and Late Outcomes of Aortic Valve Replacement in Dialysis Patients Keisuke Tanaka, MD, Kazuyoshi Tajima, MD, Yoshiyuki Takami, MD, Noritaka Okada,

Michael O. Kayatta, MD, Bradley G

Presentation transcript:

Outcomes of Tricuspid Valve Repair and Replacement: A Propensity Analysis Robert J. Moraca, MD, Marc R. Moon, MD, Jennifer S. Lawton, MD, Tracey J. Guthrie, RN, Kristen A. Aubuchon, BS, Nader Moazami, MD, Michael K. Pasque, MD, Ralph J. Damiano, MD The Annals of Thoracic Surgery Volume 87, Issue 1, Pages 83-89 (January 2009) DOI: 10.1016/j.athoracsur.2008.10.003 Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Long-term survival estimates for all patients undergoing tricuspid valve replacement (gray line [n = 93]) or repair (black line [n = 222]). The numbers of patients at risk for each group are reported at 1, 3, 5, and 10 years. The Annals of Thoracic Surgery 2009 87, 83-89DOI: (10.1016/j.athoracsur.2008.10.003) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Long-term survival estimates for all patients undergoing tricuspid valve replacement with a biologic prosthesis (black line [n = 72]) or a mechanical prosthesis (gray line [n = 21]). The numbers of patients at risk for each group are reported. The Annals of Thoracic Surgery 2009 87, 83-89DOI: (10.1016/j.athoracsur.2008.10.003) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Long-term survival estimates for all patients undergoing tricuspid valve replacement (gray line [n = 68]) or repair (black line [n = 68]) matched using propensity score analysis. The numbers of patients at risk for each group are reported. The Annals of Thoracic Surgery 2009 87, 83-89DOI: (10.1016/j.athoracsur.2008.10.003) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions